1.The diet therapy of inflammatory bowel disease: a multi-omic analysis
− Inflammatory Bowel Disease (IBD)
− Crohn's Disease
− Nutrition therapy microbiota
− Crohn's disease exclusion diet
2. Study to Evaluate Efficacy and Safety of MS-20 on Patients with Ulcerative Colitis
− Ulcerative colitis
− MS-20
3. Minimize the Risk of Infection-Related Cancers by Implementation of Microbiota Reprogramming
− HBV
− HIV
− HPV
− nasopharngeal carcinoma
− microbiology
4. Development of novel anti-allergic probiotics by gut microbiota metagenomic analysis in infant cohorts
− Allergic diseases
− Gut microbiota
− metabolites
− Prebiotics
− Probiotics
5. A Phase 3 Randomized, Open-Label Study to Assess the Efficacy, Safety, and
Pharmacokinetics of Golimumab Treatment, a Human anti-TNFα Monoclonal Antibody, Administered Subcutaneously in Pediatric Participants with Moderately to Severely Active Ulcerative Colitis
− Ulcerative colitis
− Pediatric
6. Explore the biomarkers determining the evolution of liver fibrosis and the outcome of pediatric chronic liver disease
− Microbiota
7. Gut microbiota play a critical role in determining the age-dependent outcome of hepatitis B virus infection
− Microbiota
8. The oncofetal RBMY protein and gut microbiota dysbiosis facilitate the development and metastasis of hepatocellular carcinoma
− Hepatocellular Carcinoma (HCC)
− Metastasis
− microbiota
− Epithelial–Mesenchymal Transition
9. Explore the clinical impacts of cell-free DNA as a noninvasive diagnosis of liver injury in pediatric liver transplant patients
− Liver transplant
10. Development of precision microbiome-based interventions in chronic hepatitis B
− Chronic hepatitis B
− Gut microbiota